Cargando…
Incidence of and Ivermectin Prescription Trends for COVID-19 in Japan
Autores principales: | Watari, Takashi, Tokuda, Yasuharu, Taniguchi, Kiyosu, Shibuya, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629759/ https://www.ncbi.nlm.nih.gov/pubmed/36323824 http://dx.doi.org/10.1007/s11606-022-07877-8 |
Ejemplares similares
-
Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
por: Watari, Takashi, et al.
Publicado: (2023) -
Lessons Learned from Ivermectin
por: Watari, Takashi, et al.
Publicado: (2023) -
Prevalence and characteristics of antibiotic prescription for acute COVID-19 patients in Japan
por: Hamada, Seiji, et al.
Publicado: (2022) -
Evidence‐based prescription of corticosteroids for COVID‐19 patients: A comparison between general medicine and other specialty in Japan
por: Sakaguchi, Kota, et al.
Publicado: (2022) -
Association between hospital internal medicine physician workforce and patient admissions during the COVID-19 pandemic in Japan
por: Hamada, Seiji, et al.
Publicado: (2023)